The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article
May 2021

Reminder: Zulresso only payable for inpatient facility claims

In the May 2020 Record, we notified you that Zulresso™ (brexanolone) is only payable for inpatient facility claims for Blue Cross Blue Shield of Michigan commercial members.

However, we want to let you know the HCPCS code for providing this medication is now J1632.

We’ll deny Blue Cross commercial claims for Zulresso that indicate the place of service as being other than an inpatient facility.

This applies only to in‑state providers.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2020 American Medical Association. All rights reserved.
Blue Cross Blue Shield of Michigan and Blue Care Network are nonprofit corporations and
independent licensees of the Blue Cross and Blue Shield Association.